Compound, pharmaceutical composition, corticotropin-releasing factor (crf) receptor antagonization method, dysfunction treatment method, ligand screening method, crf receptor detection method, crf binding inhibition method, article industrialized and uses of compost

摘要

"COMPOUND, PHARMACEUTICAL COMPOSITION, ANTIGONIZATION METHOD OF A CORTICOTROPINE RELEASE FACTOR (CRF), Dysfunction Treatment Method, CRD DETECTION METHOD METHOD, INDUSTRIALIZED ARTICLE AND COMPOSITE USES ". Corticotropin-releasing factor (CRF) antagonists of Formula (I) and their use in the treatment of anxiety, depression, and other psychiatric and neurological disorders, as well as in the treatment of immune, cardiovascular, or heart disease and colon hypersensitivity associated with psychopathological disorders. and tension.